SCHEMBL1710086

SCHEMBL1710086

Cc1ccccc1OCC(F)(F)C(F)F

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.45
CYP1A2 P05177 1/20 0.45
SCN4A P35499 2/20 0.44
CFTR P13569 1/20 0.43
ALDH1A1 P00352 2/20 0.42
GLA P06280 1/20 0.42
ALOX15 P16050 1/20 0.41
AOC2 O75106 1/20 0.41
MAOA P21397 1/20 0.41
MAOB P27338 1/20 0.41
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
NPSR1 Q6W5P4 2/20 0.40
LMNA P02545 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
ADRB2 P07550 1/20 0.40
ADRB1 P08588 1/20 0.40
ADRB3 P13945 1/20 0.40
TDP1 Q9NUW8 2/20 0.39
MAPT P10636 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4523648 0.81 ALDH1A1 (0.47) KDM4ECYP1A2SCN4AALDH1A1GLA
SCHEMBL1710062 0.80 CYP1A2 (0.47) KDM4ECYP1A2SCN4AALDH1A1GLA
SCHEMBL17815773 0.79 SMN1; SMN2 (0.41) KDM4EALDH1A1MEN1KMT2ANPSR1
SCHEMBL18353950 0.79 MAPT (0.44) KDM4ECYP1A2CFTRALDH1A1MEN1
SCHEMBL16773945 0.79 CFTR (0.40) KDM4ECFTRALDH1A1MEN1KMT2A
SCHEMBL28080949 0.77 SSTR4 (0.42) KDM4ECYP1A2CFTRALDH1A1MEN1
SCHEMBL17811834 0.76 HTT (0.37) KDM4EALDH1A1MEN1KMT2ANPSR1
SCHEMBL8083251 0.75 ALDH1A1 (0.48) KDM4ECYP1A2SCN4AALDH1A1GLA
SCHEMBL16757673 0.75 NPSR1 (0.39) KDM4ECFTRALDH1A1MEN1KMT2A
SCHEMBL8468869 0.75 CFTR (0.37) KDM4ECFTRALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11693310-B2 Blue curable resin composition, blue color filter, and display device including same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-07-04 US disclosed
US-11209733-B2 Oxime ester photoinitiators BASF SE 2021-12-28 US disclosed
US-11209734-B2 Oxime ester photoinitiators BASF SE 2021-12-28 US disclosed
US-11204554-B2 Oxime ester photoinitiators BASF SE 2021-12-21 US disclosed
US-20200199261-A1 HIGHLY SENSITIVE OXIME ESTER PHOTOPOLYMERIZATION INITIATOR AND PHOTOPOLYMERIZABLE COMPOSITION INCLUDING THE SAME KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2020-06-25 US disclosed
US-10488756-B2 Oxime ester photoinitiators BASF SE (DE) 2019-11-26 US disclosed
EP-3354641-B1 OXIME ESTER PHOTOINITIATORS BASF SE (DE) 2019-07-17 EP disclosed
EP-2847167-B9 OXIME ESTER PHOTOINITIATORS BASF SE (DE) 2019-02-20 EP disclosed
EP-2847167-B1 OXIME ESTER PHOTOINITIATORS BASF SE (DE) 2018-07-18 EP disclosed
EP-2963015-B1 OXIME ESTER PHOTOINITIATORS BASF SE (DE) 2018-07-11 EP disclosed
US-9051397-B2 Oxime ester BASF SE (DE) 2015-06-09 US disclosed
WO-2015080503-A1 PHOTOINITIATOR AND PHOTOSENSITIVE COMPOSITION INCLUDING THE SAME TAKOMA TECHNOLOGY CO., LTD. (KR) 2015-06-04 WO disclosed
US-20150064624-A1 OXIME ESTER PHOTOINITIATORS BASF SE (DE) 2015-03-05 US disclosed
US-20150064624-A1 OXIME ESTER PHOTOINITIATORS BASF SE (DE) 2015-03-05 US disclosed
EP-2625166-B1 OXIME ESTER DERIVATIVES OF BENZOCARBAZOLE COMPOUNDS AND THEIR USE AS PHOTOINITIATORS IN PHOTOPOLYMERIZABLE COMPOSITIONS BASF SE (DE) 2014-09-24 EP disclosed
US-20130188270-A1 OXIME ESTER BASF SE (DE) 2013-07-25 US disclosed
US-20130188270-A1 OXIME ESTER BASF SE (DE) 2013-07-25 US disclosed
WO-2012045736-A1 OXIME ESTER DERIVATIVES OF BENZOCARBAZOLE COMPOUNDS AND THEIR USE AS PHOTOINITIATORS IN PHOTOPOLYMERIZABLE COMPOSITIONS BASF SE (DE) 2012-04-12 WO disclosed
US-20070219216-A1 1-Alkylpiperazinyl-Pyrrolidin-2,5-Dione Derivatives as Adrenergic Receptor Antagonists RANBAXY LABORATORIES LIMITED (IN) 2007-09-20 US disclosed
US-20070219216-A1 1-Alkylpiperazinyl-Pyrrolidin-2,5-Dione Derivatives as Adrenergic Receptor Antagonists RANBAXY LABORATORIES LIMITED (IN) 2007-09-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11209734-B2 Oxime ester photoinitiators OR10J3, OXER1, QSOX1 KDM4E 1549/4885CYP1A2 48/4885SCN4A 1022/4885
US-10488756-B2 Oxime ester photoinitiators OR10J3, OXER1, QSOX1 KDM4E 1549/4885CYP1A2 48/4885SCN4A 1022/4885
US-11204554-B2 Oxime ester photoinitiators OR10J3, OXER1, QSOX1 KDM4E 1583/4885CYP1A2 44/4885SCN4A 1086/4885
US-20130188270-A1 OXIME ESTER CBR3, CBR1, COX15 KDM4E 2194/4885CYP1A2 103/4885SCN4A 1248/4885
US-20070219216-A1 1-Alkylpiperazinyl-Pyrrolidin-2,5-Dione Derivatives as Adrenergic Receptor Antagonists ADRA1D, ADRA1A, ADRB1 KDM4E 3759/4885CYP1A2 184/4885SCN4A 1644/4885
US-20200199261-A1 HIGHLY SENSITIVE OXIME ESTER PHOTOPOLYMERIZATION INITIATOR AND PHOTOPOLYMERIZABLE COMPOSITION INCLUDING THE SAME LCLAT1, LPO, PLOD2 KDM4E 74/4885CYP1A2 248/4885SCN4A 3911/4885
US-11209733-B2 Oxime ester photoinitiators OR10J3, OXER1, QSOX1 KDM4E 1549/4885CYP1A2 48/4885SCN4A 1022/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.